CClinicalTrials.gg
CompletedNCT06889233Updated Mar 21, 2025

MOTOR PROFICIENCY IN RELATION TO COGNITIVE FUNCTIONS AND SEVERITY IN CHILDREN WITH AUTISM SPECTRUM DISORDERS

An observational study in Autism Spectrum Disorder, sponsored by Cairo University. Completed at 1 site in Egypt. Open to participants aged 5 Years to 12 Years. Per ClinicalTrials.gov, last updated 2025-03-21.

Sponsored by Cairo University · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
64
Ages
5 Years to 12 Years
Sex
All
01

Study summary

To investigate the relationship between cognitive function, the severity of autism spectrum disorder (ASD), and the development of fine and gross motor skills in children with ASD

Read the detailed description

A sample of 64 children with autism aged from 5 to 12 years recruited from centres and schools of special needs for intellectual and developmental disabilities to measure cognitive function using the Raven's Progressive Matrices and measure the severity of autism using the Childhood Autism Rating Scale (CARS). These assessments will then be compared with the children's fine and gross motor abilities

02

Conditions studied

  • Autism Spectrum Disorder

Keywords

  • AUTISM
  • ASD
  • RAVEN
  • CARS
  • BOT2
  • FINE MOTOR SKILLS
  • Gross motor skills
03

In context

Autistic Disorder

1,344 studies on the registry are indexed under Autistic Disorder; 334 are open to participants now.

This study's enrollment of 64 is below the median of 102 across 267 observational studies indexed under Autistic Disorder.

Browse Autistic Disorder studies →

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

autistic children age ranged from 5 to 12 years

Inclusion criteria

  1. Children had been diagnosed with ASD.
  2. Their chronological age ranged from 5 years to 12 years.
  3. Intelligence quotient (IQ) ranged from 55 to 85.

Exclusion criteria

Exclusion criteria:

Any child with the following criteria would be directly excluded from the evaluation for the consistency of the sample and statistically obtained results:

  1. The child with ASD and other motor disabilities.
  2. Visual or hearing impairment.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
64 participants (actual)
Patient registry
No

Groups and cohorts

  • observational group

    We will assess cognitive function using the Raven's Progressive Matrices and measure the severity of autism using the Childhood Autism Rating Scale (CARS). These assessments will then be compared with the children's fine and gross motor abilities using BOT2 .

    Behavioral: measuring cognitive functions, severity of autism , gross and fine motor skills

Interventions

  • Behavioralmeasuring cognitive functions, severity of autism , gross and fine motor skills

    measuring cognitive functions by RAVEN measuring severity by CARS measuring fine and gross motor functions by BOT2

06

What researchers measure

Primary outcomes

  1. measuring motor proficiency (gross & fine motor skills ) by using BOT2 scale

    Time frame: 12 weeks

Secondary outcomes

  1. measuring cognitive functions by RAVEN Progressive matrices

    this scale items like puzzle and the child must extract the missed part from six choices

    Time frame: 12 weeks

Other outcomes

  1. measuring severity of autism by using CARS scale

    this scale like questionnaire consisted of 15 question and parents or teacher give answers to this questions

    Time frame: 12 weeks

07

Study locations

1 site
  • Faculty of physical therapy cairo university
    Cairo, Dokki 12613, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06889233
Lead sponsor
Cairo University
Responsible party
Aya Gamal Ali Abdelmoniem (senior physiotherapist, Cairo University) — Principal investigator
First posted
Mar 21, 2025
Start date
Mar 1, 2023
Primary completion
Jun 1, 2024
Completion
Aug 1, 2024
Last update
Mar 21, 2025

Study contacts

Heba Kamal professor, professor of physical therapy
study chair · Cairo University
Alaa fahmy hassan El Nemer, lecturer of physical therapy
study director · Cairo University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion